Inactivation of human SRBC, located within the 11p15.5-P15.4 tumor suppressor region, in breast and lung cancers

Cancer Research

Volumn 61, Issue 21, 2001, Pages 7943-7949

  Xu, Xie L ^a   Wu, Leeju C ^b   Du, Fenghe ^e   Davis, Arthur ^f   Peyton, Michael ^a   Tomizawa, Yoshio ^a   Maitra, Anirban ^a   Tomlinson, Gail ^a   Gazdar, Adi F ^a   Weissman, Bernard E ^f   Bowcock, Anne M ^e   Baer, Richard ^c,d   Minna, John D ^a  

^a Hamon Center for Therapeutic Oncology Research   (United States)

^b Department of Biochemistry ^*  (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d Columbia University College of Physicians and Surgeons New York ^*  (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; BRCA1 PROTEIN; COMPLEMENTARY DNA; DINUCLEOTIDE; GENE PRODUCT; SRBC PROTEIN; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN MCF 7; CHILDHOOD CANCER; CHROMOSOME 11P; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FRAMESHIFT MUTATION; GENE INACTIVATION; GENE ISOLATION; GENE MAPPING; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LUNG CANCER; MOLECULAR CLONING; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CARRIER PROTEINS; CHICKENS; CHROMOSOMES, HUMAN, PAIR 11; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); RADIATION HYBRID MAPPING; RATS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0035503031     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Loss of heterozygosity at chromosome in breast cancer: Association of prognostic factors with genetic alterations
2. Loss of heterozygosity for chromosome II in primary human breast tumors is associated with poor survival after metastasis
3. Two distinct tumor suppressor loci within chromosome II p15 implicated in breast cancer progression and metastasis
4. Association of chromosome locus D11S12 with histology, stage, and metastases in lung cancer
5. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas
6. Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor
7. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours
8. Deletion mapping of chromosome in carcinoma of the bladder
9. Loss of heterozygosity for chromosome in adenocarcinoma of the stomach
10. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver
11. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: Identification of two independent regions
12. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5
13. Loss of allelic heterozygosity at a second locus on chromosome in sporadic Wilms' tumor cells
14. A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5
15. Allelotype of pediatric rhabdomyosarcoma
16. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma
17. Definition and refinement of chromosome regions of loss of heterozygosity in breast cancer: Identification of a new region at 11q23.3
18. Reduction to homozygosity of genes on chromosome in human breast neoplasia
19. Imprinting in clusters: Lessons from Beckwith-Wiedemann syndrome
20. A-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA-and the BWSCR/WT2 region
21. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer
22. Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH-A and LOH-B
23. Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome
24. Growth inhibition of a human lung adenocarcinoma cell line by genetic complementation with chromosome
25. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay
26. Enrichment of epithelial cells for molecular studies
27. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma
28. Identification of a RING protein that can interact in vivo with the BRCA-gene product
29. High sensitivity mapping of methylated cytosines
30. A protein kinase C-binding protein SRBC whose expression is induced by serum starvation
31. Activation of human c-raf-by replacing the N-terminal region with different sequences
32. Serum deprivation response gene is induced by serum starvation but not by contact inhibitio
33. Cloning functional characterization of PTRF: A novel protein which induces dissociation of paused ternary transcription complexes
34. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering
35. Cell cycle-dependent colocalization of BARD-and BRCA-proteins in discrete nuclear domains
36. Cancer epigenetics comes of age
37. PANORAMA: An integrated web-based sequence analysis tool and its role in gene discovery
38. Alterations in DNA methylation: A fundamental aspect of neoplasia
39. Targeting of protein kinase C-α to caveolae
40. The human serum deprivation response gene (SDPR) maps to 2q32-q33 and codes for a phosphatidylserine-binding protein
41. Purification and characterization of a major phosphatidylserine-binding phosphoprotein from human platelets
42. Deletion mapping of chromosome 2 in human lung carcinoma
43. Breakpoint junction of interstitial homozygous deletion at chromosome 2q33 in a small cell lung carcinoma
44. Isolation of cDNAs representing dithiolethione-responsive genes
45. Protein kinase C-8
46. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
47. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13
48. BRCA-mutations in primary breast and ovarian carcinomas
49. Brcacontrols homology-directed DNA repair
50. BRCA-required for transcription-coupled repair of oxidative DNA damage